- Home
- KINS vs DRTS Comparison
KINS vs DRTS Comparison
Compare KINS & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KINS
- DRTS
- Stock Information
- Founded
- KINS 1886
- DRTS 2015
- Country
- KINS United States
- DRTS Israel
- Employees
- KINS N/A
- DRTS N/A
- Industry
- KINS Property-Casualty Insurers
- DRTS Medical/Dental Instruments
- Sector
- KINS Finance
- DRTS Health Care
- Exchange
- KINS Nasdaq
- DRTS Nasdaq
- Market Cap
- KINS 251.5M
- DRTS 262.6M
- IPO Year
- KINS N/A
- DRTS N/A
- Fundamental
- Price
- KINS $16.30
- DRTS $2.99
- Analyst Decision
- KINS Strong Buy
- DRTS Strong Buy
- Analyst Count
- KINS 1
- DRTS 2
- Target Price
- KINS $6.50
- DRTS $8.00
- AVG Volume (30 Days)
- KINS 428.3K
- DRTS 51.5K
- Earning Date
- KINS 05-08-2025
- DRTS 05-19-2025
- Dividend Yield
- KINS N/A
- DRTS N/A
- EPS Growth
- KINS 5417.04
- DRTS N/A
- EPS
- KINS 1.60
- DRTS N/A
- Revenue
- KINS $169,875,701.00
- DRTS N/A
- Revenue This Year
- KINS $40.63
- DRTS N/A
- Revenue Next Year
- KINS $6.92
- DRTS N/A
- P/E Ratio
- KINS $10.21
- DRTS N/A
- Revenue Growth
- KINS 18.52
- DRTS N/A
- 52 Week Low
- KINS $4.55
- DRTS $1.75
- 52 Week High
- KINS $22.40
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- KINS 45.69
- DRTS 55.04
- Support Level
- KINS $15.63
- DRTS $2.95
- Resistance Level
- KINS $17.54
- DRTS $3.12
- Average True Range (ATR)
- KINS 1.09
- DRTS 0.21
- MACD
- KINS -0.18
- DRTS -0.00
- Stochastic Oscillator
- KINS 9.90
- DRTS 31.33
About KINS Kingstone Companies Inc.
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.